On February 28, 2023 AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, reported that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in the following three investor conferences in March (Press release, AngioDynamics, FEB 28, 2023, View Source [SID1234627917]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Raymond James Institutional Investors Conference
Format: In-person Presentation
Date: Monday, March 6, 2023
Time: 8:05 a.m. ET
Location: Orlando, FL

Oppenheimer Virtual Healthcare Conference
Format: Fireside Chat
Date: Monday, March 13, 2023
Time: 9:20 a.m. ET

KeyBanc Virtual Life Sciences & MedTech Investor Forum
Format: Fireside Chat
Date: Tuesday, March 21, 2023
Time: 4:30 p.m. ET

A live webcast of each presentation will be accessible through the "Investors" section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.